ZOLL Donates AED’s and Training to Burlington P.D.

In recognition of the role Police Chief Fran Hart and the Burlington (MA) Police Department played in the development of ZOLL’s AED Plus, ZOLL has donated 24 AED Plus devices, plus the required training and certification, to the Burlington PD. The donation is valued at $60,000.

In 1999, then-Lieutenant Fran Hart was first approached by Fred Faller, ZOLL’s principal mechanical engineer and designer (and Burlington resident), asking for the PD’s input in developing the AED Plus. Thanks to the Department’s insight and ideas, several changes were made to the device’s original design. The final product meets the requirements of the first responder and public access markets. These markets include EMTs and fire personnel, plus trained laypersons such as security guards, flight attendants and office managers. For more information on ZOLL products, visit www.zoll.com.

ZOLL Medical Corporation, headquartered in Burlington, MA, designs, manufactures and markets an integrated line of proprietary, non-invasive resuscitation devices and disposable electrodes. Used by health care professionals to provide both types of cardiac resuscitation-pacing and defibrillation-these products are essential in the emergency treatment of cardiac arrest victims, both inside and outside the hospital. ZOLL also designs and markets software that automates collection and management of both clinical and non-clinical data for emergency medical service providers. ZOLL has operations in the United States, Canada, United Kingdom, Germany, France, the Netherlands and Australia, and business partners in all of the world’s major markets. For more information about ZOLL and its products, visit www.zoll.com.

Certain statements contained in this press release, including statements regarding the anticipated development of ZOLL’s business, the intent, belief or current expectations of ZOLL, its directors or its officers, primarily with respect to ZOLL’s business model and future operating performance of ZOLL, including expectations regarding results in future periods, operating performance and contributions to results from ZOLL’s new Public Access Defibrillation product, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the ZOLL’s Annual Report on Form 10-Q filed on February 12, 2003, including the future performance of the direct sales operations, as well as uncertainties regarding the market, acceptance and profitability of the ZOLL AED Plus and M Series CCT, the length and severity of the current economic slowdown and its impact on capital spending budgets, the reduction in overall capital equipment expenditures in the hospital and pre-hospital markets, the impact of governmental budget restraints on the purchase of capital equipment, the impact of the continued war on terrorism, the potential disruption in the transportation industry on ZOLL’s supply chain and product distribution channels, and the desire or ability of other parties to purchase ZOLL’s products.

Please contact your local ZOLL representative at (800)348-9011 for more information on Zoll Products.